The layoffs across GSK’s Belgium sites come on the heels of the pharma’s planned shuttering of its German vaccine manufacturing site, which prompted job cuts for about 650 employees.
GSK plans 1.2K+ layoffs at Belgium sites as $2.5B restructure gains momentum